» News » J&J in talks with India for study of single-dose vaccine

J&J in talks with India for study of single-dose vaccine

Source: PTI   -  Edited By: Roshneesh Kmaneck
April 09, 2021 16:47 IST
Get Rediff News in your Inbox:

Global healthcare major Johnson & Johnson is in discussions with the Indian government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday.

IMAGE: Johnson & Johnson's coronavirus disease vaccines at Northwell Health's South Shore University Hospital in Bay Shore, New York, US. Photograph: Shannon Stapleton/Reuters

The United States Food and Drug Administration has already approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use in February.

"We are in discussions with the Government of India with the objective of starting a bridging clinical study of our Janssen COVID-19 vaccine candidate in India, subject to local regulatory approvals," Johnson & Johnson India spokesperson said in an email reply.


Johnson & Johnson's vaccine can be stored at refrigerator temperatures.

"At Johnson & Johnson, we remain fully focused on bringing a safe and effective COVID-19 vaccine to people around the world, if authorised for use by local health authorities", the spokesperson said.

India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.

India registered a record single-day spike of 1,31,968 new COVID-19 cases on Friday, pushing its infection tally to 1,30,60,542, while the death toll increased to 1,67,642 with 780 more fatalities in a day, the highest since October 18, the Union health ministry data showed.

Get Rediff News in your Inbox:
Source: PTI  -  Edited By: Roshneesh Kmaneck© Copyright 2021 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
The War Against Coronavirus

The War Against Coronavirus